• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非缺血性扩张型心肌病晚期钆增强分布模式:基因型-表型相关性。

Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype-phenotype correlation.

机构信息

Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro, Manuel de Falla, 2, Majadahonda, Madrid, 28222, Spain.

CIBER Cardiovascular, Instituto de Salud Carlos III, Avenida Monforte de Lemos 3-5, ‌Madrid, 28029, Spain.

出版信息

Eur Heart J Cardiovasc Imaging. 2023 Dec 21;25(1):75-85. doi: 10.1093/ehjci/jead184.

DOI:10.1093/ehjci/jead184
PMID:37562008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10735304/
Abstract

AIMS

Late gadolinium enhancement (LGE) is frequently found in patients with dilated cardiomyopathy (DCM); there is little information about its frequency and distribution pattern according to the underlying genetic substrate. We sought to describe LGE patterns according to genotypes and to analyse the risk of major ventricular arrhythmias (MVA) according to patterns.

METHODS AND RESULTS

Cardiac magnetic resonance findings and LGE distribution according to genetics were performed in a cohort of 600 DCM patients followed at 20 Spanish centres. After exclusion of individuals with multiple causative gene variants or with variants in infrequent DCM-causing genes, 577 patients (34% females, mean age 53.5 years, left ventricular ejection fraction 36.9 ± 13.9%) conformed to the final cohort. A causative genetic variant was identified in 219 (38%) patients, and 147 (25.5%) had LGE. Significant differences were found comparing LGE patterns between genes (P < 0.001). LGE was absent or rare in patients with variants in TNNT2, RBM20, and MYH7 (0, 5, and 20%, respectively). Patients with variants in DMD, DSP, and FLNC showed a predominance of LGE subepicardial patterns (50, 41, and 18%, respectively), whereas patients with variants in TTN, BAG3, LMNA, and MYBPC3 showed unspecific LGE patterns. The genetic yield differed according to LGE patterns. Patients with subepicardial, lineal midwall, transmural, and right ventricular insertion points or with combinations of LGE patterns showed an increased risk of MVA compared with patients without LGE.

CONCLUSION

LGE patterns in DCM have a specific distribution according to the affected gene. Certain LGE patterns are associated with an increased risk of MVA and with an increased yield of genetic testing.

摘要

目的

在扩张型心肌病(DCM)患者中经常发现晚期钆增强(LGE);根据潜在的遗传基础,关于其频率和分布模式的信息很少。我们试图根据基因型描述 LGE 模式,并根据模式分析主要室性心律失常(MVA)的风险。

方法和结果

在 20 个西班牙中心进行的 600 名 DCM 患者的队列中进行了心脏磁共振检查和遗传基础上的 LGE 分布。在排除了具有多种致病基因变异或罕见的 DCM 致病基因变异的个体后,577 名患者(34%为女性,平均年龄 53.5 岁,左心室射血分数 36.9±13.9%)符合最终队列。在 219 名(38%)患者中发现了致病基因变异,147 名(25.5%)有 LGE。基因之间的 LGE 模式存在显著差异(P<0.001)。在 TNNT2、RBM20 和 MYH7 变异患者中,LGE 缺失或罕见(分别为 0、5 和 20%)。在 DMD、DSP 和 FLNC 变异患者中,LGE 表现为心外膜下优势模式(分别为 50%、41%和 18%),而在 TTN、BAG3、LMNA 和 MYBPC3 变异患者中,LGE 模式无特异性。根据 LGE 模式,遗传检出率不同。与无 LGE 的患者相比,具有心外膜下、线性中壁、透壁和右室插入点或具有 LGE 模式组合的患者发生 MVA 的风险增加。

结论

DCM 中的 LGE 模式根据受影响的基因具有特定的分布。某些 LGE 模式与 MVA 风险增加和遗传检测产率增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7697/10735304/272e7044bd13/jead184f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7697/10735304/843584797bae/jead184_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7697/10735304/a5ba3790eec9/jead184f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7697/10735304/37ef151a3ff3/jead184f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7697/10735304/9e664f074091/jead184f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7697/10735304/272e7044bd13/jead184f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7697/10735304/843584797bae/jead184_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7697/10735304/a5ba3790eec9/jead184f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7697/10735304/37ef151a3ff3/jead184f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7697/10735304/9e664f074091/jead184f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7697/10735304/272e7044bd13/jead184f4.jpg

相似文献

1
Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype-phenotype correlation.非缺血性扩张型心肌病晚期钆增强分布模式:基因型-表型相关性。
Eur Heart J Cardiovasc Imaging. 2023 Dec 21;25(1):75-85. doi: 10.1093/ehjci/jead184.
2
[Late gadolinium enhancement distribution pattern of left ventricular wall in patients with dilated cardiomyopathy: a preliminary study].扩张型心肌病患者左心室壁延迟钆增强分布模式的初步研究
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Nov 24;48(11):922-929. doi: 10.3760/cma.j.cn112148-20200813-00638.
3
Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy.晚期钆增强与基因型联合改善非缺血性扩张型心肌病的预后预测。
Eur J Heart Fail. 2022 Jul;24(7):1183-1196. doi: 10.1002/ejhf.2514. Epub 2022 May 22.
4
Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.扩张型心肌病和致心律失常性左室心肌病:一项综合的基因型-影像表型研究。
Eur Heart J Cardiovasc Imaging. 2020 Mar 1;21(3):326-336. doi: 10.1093/ehjci/jez188.
5
Prognostic impact of late gadolinium enhancement at the right ventricular insertion points in non-ischaemic dilated cardiomyopathy.非缺血性扩张型心肌病右心室插入点延迟钆增强的预后影响
Eur Heart J Cardiovasc Imaging. 2023 Feb 17;24(3):346-353. doi: 10.1093/ehjci/jeac109.
6
Ring-like late gadolinium enhancement for predicting ventricular tachyarrhythmias in non-ischaemic dilated cardiomyopathy.环形晚期钆增强预测非缺血性扩张型心肌病室性心动过速/颤动。
Eur Heart J Cardiovasc Imaging. 2021 Sep 20;22(10):1130-1138. doi: 10.1093/ehjci/jeab117.
7
Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis.晚期钆增强与扩张型心肌病中心律失常或猝死风险:系统评价和荟萃分析。
JACC Heart Fail. 2017 Jan;5(1):28-38. doi: 10.1016/j.jchf.2016.09.017. Epub 2016 Dec 21.
8
Ventricular Arrhythmias and Sudden Death in Nonischemic Dilated Cardiomyopathy: Matter of Sex or Scar?非缺血性扩张型心肌病中的室性心律失常和心原性猝死:与性别相关还是与瘢痕相关?
J Card Fail. 2022 Aug;28(8):1278-1286. doi: 10.1016/j.cardfail.2022.01.019. Epub 2022 Feb 15.
9
Assessing the association between genetic and phenotypic features of dilated cardiomyopathy and outcome in patients with coronary artery disease.评估扩张型心肌病的遗传和表型特征与冠心病患者预后的相关性。
Eur J Heart Fail. 2024 Jan;26(1):46-55. doi: 10.1002/ejhf.3033. Epub 2023 Oct 5.
10
[T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].用于扩张型心肌病诊断的T1映射和延迟钆增强
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Dec;32(12):1506-1510. doi: 10.3760/cma.j.cn121430-20200413-00287.

引用本文的文献

1
Cardiac Magnetic Resonance in Heart Failure: Diagnostic and Prognostic Assessments.心力衰竭中的心脏磁共振成像:诊断与预后评估
J Cardiovasc Dev Dis. 2025 May 23;12(6):200. doi: 10.3390/jcdd12060200.
2
Dilated Cardiomyopathy in a Young Patient With an Gene Mutation.一名携带基因突变的年轻患者的扩张型心肌病
Case Rep Med. 2025 Jun 8;2025:7792307. doi: 10.1155/carm/7792307. eCollection 2025.
3
Highlights of the Society for Cardiovascular Magnetic Resonance 2025 conference: Leading the way to accessible, efficient, and sustainable cardiovascular magnetic resonance.

本文引用的文献

1
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
2
Prognostic impact of late gadolinium enhancement at the right ventricular insertion points in non-ischaemic dilated cardiomyopathy.非缺血性扩张型心肌病右心室插入点延迟钆增强的预后影响
Eur Heart J Cardiovasc Imaging. 2023 Feb 17;24(3):346-353. doi: 10.1093/ehjci/jeac109.
3
2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders.
心血管磁共振学会2025年会议亮点:引领通往可及、高效和可持续的心血管磁共振之路。
J Cardiovasc Magn Reson. 2025 May 23;27(2):101914. doi: 10.1016/j.jocmr.2025.101914.
4
Feasibility and Role of Cardiac Magnetic Resonance in Intensive and Acute Cardiovascular Care.心脏磁共振成像在重症及急性心血管护理中的可行性及作用
J Clin Med. 2025 Feb 9;14(4):1112. doi: 10.3390/jcm14041112.
5
Genotype-phenotype insights of pediatric dilated cardiomyopathy.小儿扩张型心肌病的基因型-表型见解
Front Pediatr. 2025 Jan 31;13:1505830. doi: 10.3389/fped.2025.1505830. eCollection 2025.
6
Inflammation clashing onto myocardial susceptibility: a tale of two rare diseases-a case report.炎症与心肌易感性的碰撞:两种罕见疾病的故事——一例病例报告
Eur Heart J Case Rep. 2025 Jan 29;9(2):ytaf047. doi: 10.1093/ehjcr/ytaf047. eCollection 2025 Feb.
7
Shaping cardiac diagnostics: The role of myocardial tissue mapping in unraveling ring-like fibrosis.塑造心脏诊断:心肌组织图谱在揭示环状纤维化中的作用。
Cardiol J. 2025;32(1):62-72. doi: 10.5603/cj.101260. Epub 2025 Feb 6.
8
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Dilated Left Ventricular Cardiomyopathy: a sub-study from the DERIVATE Registry.非扩张型左室心肌病患者预防性植入式心律转复除颤器治疗的心脏磁共振成像:DERIVATE注册研究的一项子研究
Eur Heart J Cardiovasc Imaging. 2025 Feb 3. doi: 10.1093/ehjci/jeaf043.
9
Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy.心脏磁共振成像在扩张型心肌病患者预后评估和风险分层中评估心肌纤维化的应用
Rev Cardiovasc Med. 2025 Jan 14;26(1):25654. doi: 10.31083/RCM25654. eCollection 2025 Jan.
10
Unraveling the Genetic Heartbeat: Decoding Cardiac Involvement in Duchenne Muscular Dystrophy.解读基因心跳:解码杜氏肌营养不良症中的心脏受累情况。
Biomedicines. 2025 Jan 4;13(1):102. doi: 10.3390/biomedicines13010102.
2022 HRS 专家共识声明:神经肌肉疾病中心律失常风险的评估与管理。
Heart Rhythm. 2022 Oct;19(10):e61-e120. doi: 10.1016/j.hrthm.2022.04.022. Epub 2022 Apr 29.
4
Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy.晚期钆增强与基因型联合改善非缺血性扩张型心肌病的预后预测。
Eur J Heart Fail. 2022 Jul;24(7):1183-1196. doi: 10.1002/ejhf.2514. Epub 2022 May 22.
5
External validation of an algorithm for risk stratification of ventricular arrhythmia in nonischemic dilated cardiomyopathy.非缺血性扩张型心肌病中心室心律失常风险分层算法的外部验证
Rev Esp Cardiol (Engl Ed). 2022 Aug;75(8):684-685. doi: 10.1016/j.rec.2022.01.001. Epub 2022 Feb 18.
6
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants.致心律失常性右室心肌病 1 型相关蛋白基因突变致心肌病变的表型表达、自然病史和危险分层。
Circulation. 2021 Nov 16;144(20):1600-1611. doi: 10.1161/CIRCULATIONAHA.121.053521. Epub 2021 Sep 30.
7
Clinical characteristics and risk stratification of desmoplakin cardiomyopathy.桥粒芯糖蛋白心肌病的临床特征和危险分层。
Europace. 2022 Feb 2;24(2):268-277. doi: 10.1093/europace/euab183.
8
Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy.非缺血性扩张型心肌病患者室性心律失常和猝死的风险分层改善。
J Am Coll Cardiol. 2021 Jun 15;77(23):2890-2905. doi: 10.1016/j.jacc.2021.04.030.
9
Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy.无严重骨骼肌病的抗肌萎缩蛋白相关扩张型心肌病的患病率及临床结局
Eur J Heart Fail. 2021 Aug;23(8):1276-1286. doi: 10.1002/ejhf.2250. Epub 2021 Jun 9.
10
Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients With Nonischemic Cardiomyopathy.非缺血性心肌病患者左心室射血分数和心肌瘢痕与长期死亡风险及死亡方式的关系
Circulation. 2021 Apr 6;143(14):1343-1358. doi: 10.1161/CIRCULATIONAHA.120.048477. Epub 2021 Jan 22.